TAYLOR FIVEASH: Open Payments
NPI 1962922427 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 8 payments from 5 companies in 2025. Trend: 2023 $4,546 · 2024 $125 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $85 |
| Boston Scientific Corporation | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Amgen Inc. | 1 | $13 |
Products named: Kerendia, WATCHMAN FLX, CAMZYOS, AMVUTTRA, General - CRM_CRM, REPATHA.
Industry payments across GA — which companies pay providers there.
